-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CFl8MBnm5Xg1+Y9wRqJmlz5upfJQKb8pjmbaIdQl+6MsJlVVXRypWOHX12mQIlYC h5dbrSmQLSaNAqTU49BsaA== 0000936392-98-001354.txt : 19981016 0000936392-98-001354.hdr.sgml : 19981016 ACCESSION NUMBER: 0000936392-98-001354 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981013 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: 2834 IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-18725 FILM NUMBER: 98724876 BUSINESS ADDRESS: STREET 1: 9333 GENESEE AVENUE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195879333 MAIL ADDRESS: STREET 1: 9333 GENESEE AVENUE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 POS AM 1 POST-EFFECTIVE AMENDMENT 1 SUPPLEMENT TO PROSPECTUS DATED JUNE 8, 1998 445,000 SHARES HOLLIS-EDEN PHARMACEUTICALS, INC. COMMON STOCK ------------------------ The Prospectus dated June 8, 1998, as supplemented on June 25, 1998, is hereby supplemented as follows to restate, in its entirety, the "Selling Stockholders" section on page 8 of the Prospectus: SELLING STOCKHOLDERS The following table sets forth the names of the Selling Stockholders and the number of shares of Common Stock owned beneficially by them as of October 13, 1998 which may be offered pursuant to this Prospectus. Because the Selling Stockholders may offer all, some or none of their respective warrants or shares of Common Stock, no definitive estimate as to the number of shares thereof that will be held by the Selling Stockholders after such offering can be provided. The term "Selling Stockholder" includes the holders listed below and their transferees, pledgees, donees or other successors.
NAME SHARES BEING OFFERED ---- -------------------- MDB Capital Group LLC................................. 290,400 LHIP Acquisition Company, LLC(1)...................... 128,700 Aaron A. Grunfeld..................................... 10,000 Jane Flood............................................ 5,400 Jeffrey Sun........................................... 2,500 Peter Alpert.......................................... 1,000 Sheldon Berger........................................ 1,000 David Gitman.......................................... 1,000 Lee Polster........................................... 1,000 Nicholas Ramniceanu................................... 1,000 Ronald Resch.......................................... 1,000 Martin Castle......................................... 1,000 MacDonald Bowyer...................................... 500 Ben Lupu.............................................. 500 ------- Total....................................... 445,000 =======
- - --------------- (1) Paul Bagley, a director of Hollis-Eden, is the manager of LHIP Management Company, LLC, which is the manager of LHIP Acquisition Company, LLC. As the manager of LHIP Management Company, LLC, Mr. Bagley has the right to exercise and dispose, or direct disposition, of the warrants held by LHIP Acquisition Company, LLC and the Common Stock issuable upon exercise of such warrants. Except as set forth above, none of the Selling Stockholders has, or within the past three years has had, any position, office or other material relationship with the Company or any of its predecessors or affiliates. The date of this Prospectus Supplement is October 13, 1998.
-----END PRIVACY-ENHANCED MESSAGE-----